1. CDDO and Its Role in Chronic Diseases
   Bryan J. Mathis et al, 2016, Drug Discovery from Mother Nature CrossRef
2. Synthetic oleanane triterpenoid derivative CDDO‐Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5
   Percy D. P. Akuetteh et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
3. NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferation
   Yongfeng Guo et al, 2017, Biomedicine & Pharmacotherapy CrossRef
4. The role of natural products in revealing NRF2 function
   Donna D. Zhang et al, 2020, Natural Product Reports CrossRef
5. Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells
   Abdullah Shopit et al, 2021, Phytomedicine CrossRef
6. Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase
   Songting Shou et al, 2024, Cancer Gene Therapy CrossRef
7. Molecular Repolarisation of Tumour-Associated Macrophages
   Floris van Dalen et al, 2018, Molecules CrossRef
8. The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
   Christopher J. Occhiuto et al, 2023, Molecules and Cells CrossRef
9. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment
   Jorge A.R. Salvador et al, 2017, European Journal of Medicinal Chemistry CrossRef
10. Location, Orientation and Aggregation of Bardoxolone-ME, CDDO-ME, in a Complex Phospholipid Bilayer Membrane
    Vicente Galiano et al, 2020, The Journal of Membrane Biology CrossRef
11. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
    Emiliano Panieri et al, 2021, Antioxidants & Redox Signaling CrossRef
12. Prophylactic and therapeutic roles of oleanolic acid its derivatives in several diseases
    Alaattin Sen, 2020, World Journal of Clinical Cases CrossRef